Industry
Pharmaceuticals
Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.
Total Companies
1 295
1 241 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
Eli Lilly and Co
LLY
|
$1 001.35 |
-1.4%
|
$946.7B |
|
|
|
Johnson & Johnson
JNJ
|
$243.71 |
+0.6%
|
$587.2B |
|
|
|
Roche Holding AG
ROG
|
CHf335.9 |
-0.4%
|
$351.3B |
|
|
|
Novartis AG
NOVN
|
CHf122.44 |
+0.1%
|
$303.7B |
|
|
|
AstraZeneca PLC
AZN
|
GBX14 600 |
-0.1%
|
$305.5B |
|
|
|
Merck & Co Inc
MRK
|
$117.09 |
+0.3%
|
$290.6B |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr247.3 |
-1.9%
|
$173.2B |
|
|
|
Pfizer Inc
PFE
|
$27.16 |
+0.4%
|
$154.4B |
|
|
|
Bristol-Myers Squibb Co
BMY
|
$60.13 |
+0.6%
|
$122.4B |
1 236 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account
